Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Technology
Technology

Nanox.AI's Investigational HealthAVC Solution Demonstrates 98.3% Sensitivity And 96.6% Specificity In Evaluable CT Scans

Nov 2, 2026 · 08:11 AM ET· updated 1h ago

Nanox.AI's Investigational AVC Solution Demonstrated 98.3% Sensitivity and 96.6% Specificity in Evaluable CT Scans.Findings Highlight the Potential of AI to Identify Previously Unreported Aortic Valve Calcification

Share
Why It Matters

Nanox's AI tool found heart valve problems very accurately in test scans. When a tool works this well in tests, it hints the company might help doctors soon.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
NNOX0.33
+0.00 (+0.79%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.